The overall response rate was 69.4% (95% CI, 62.4%75.8%) in the selpercatinib group and 38.8% (95% CI, 29.1%49.2%) in the control group
No need to worry about taking pills daily or preparing complicated meals
Benefits Tesamorelin + Ipamorelin is believed to help with: Targeted visceral fat reduction: Tesamorelin has been shown to reduce VAT area and improve VAT quality and lipid profiles while sparing subcutaneous fat, supporting both health and aesthetics. Lean mass and recovery support: Ipamorelin selectively boosts GH/IGF1 to promote protein synthesis, lean mass, strength, and exercise recovery with a favorable sideeffect profile compared with many GH secretagogues. Improved recomposition and performance: Stacking the two can yield better waistlines, tighter midsections, stronger training sessions, and more resilient recovery than either alone when combined with strength training and adequate protein. Labguided, cyclical use: Protocols often run 8-12 weeks with 5dayson/2daysoff injections, periodic breaks, and monitoring of IGF1, glucose, and lipids to align benefits with safety.
Studies using acute, sub-chronic, or chronic caffeine/xanthines exposure protocol
In SURMOUNT-1, a 72-week trial, adults on the highest branded tirzepatide dose (15 mg) lost roughly 20%
)
